These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26557668)

  • 1. Is It Time to Beta Block the Septic Patient?
    Pemberton P; Veenith T; Snelson C; Whitehouse T
    Biomed Res Int; 2015; 2015():424308. PubMed ID: 26557668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic response to β-blockers in severe sepsis and septic shock: A review of current literature.
    van Loon LM; van der Hoeven JG; Lemson J
    J Crit Care; 2019 Apr; 50():138-143. PubMed ID: 30540967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockers in septic shock: a review.
    Vela-Vásquez RS; Grigorov-Tzenkov I; Aguilar JL
    Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):90-5. PubMed ID: 25152109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-blockers in Septic Shock].
    Uhlig C; Spieth PM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2018 Nov; 53(11-12):787-792. PubMed ID: 30458576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature.
    Eraky AM; Yerramalla Y; Khan A; Mokhtar Y; Alamrosy M; Farag A; Wright A; Grounds M; Gregorich NM
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new frontier for an old drug? A word of caution for beta-blockers in sepsis!
    Maybauer MO; Maybauer DM
    Curr Med Res Opin; 2015; 31(10):1829-30. PubMed ID: 26296157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-blockers in septic shock: are we there yet?
    Cruz MC; Reis L
    Rev Bras Ter Intensiva; 2017; 29(1):1-3. PubMed ID: 28444065
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blocker use in severe sepsis and septic shock: a systematic review.
    Sanfilippo F; Santonocito C; Morelli A; Foex P
    Curr Med Res Opin; 2015; 31(10):1817-25. PubMed ID: 26121122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis and beta-blockade: a look into diastolic function.
    Astuto M
    Curr Med Res Opin; 2015; 31(10):1827-8. PubMed ID: 26211819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers in intensive care medicine: potential benefit in acute brain injury and acute respiratory distress syndrome.
    van der Jagt M; Miranda DR
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):141-51. PubMed ID: 22642505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic blockade and glucoregulation in endotoxin shock.
    Filkins JP
    Circ Shock; 1979; 6(2):99-107. PubMed ID: 36999
    [No Abstract]   [Full Text] [Related]  

  • 12. β-blockers in critically ill patients: from physiology to clinical evidence.
    Coppola S; Froio S; Chiumello D
    Crit Care; 2015 Mar; 19(1):119. PubMed ID: 25882896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta-blockers in septic patients.
    Hamzaoui O; Teboul JL
    Minerva Anestesiol; 2015 Mar; 81(3):312-9. PubMed ID: 24941896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
    Mio Y
    Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for dopexamine hydrochloride in septic shock.
    Murphy R
    Ir Med J; 1998; 91(5):180. PubMed ID: 9973758
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta-blockers in flow of time--view of an anaesthesiologist and intensivist].
    Cvachovec K
    Cas Lek Cesk; 2010; 149(6):288-90. PubMed ID: 20662477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bench-to-bedside review: Beta-adrenergic modulation in sepsis.
    de Montmollin E; Aboab J; Mansart A; Annane D
    Crit Care; 2009; 13(5):230. PubMed ID: 19863760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
    Barbier GH; Shettigar UR; Appunn DO
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Esmolol--beta-adrenergic blocking agent with ultrashort action].
    Marenović T; Stojiljković MP; Marković M
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():65-70. PubMed ID: 18193815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.